GB1276089A - Pharmaceutical preparations - Google Patents

Pharmaceutical preparations

Info

Publication number
GB1276089A
GB1276089A GB4041268A GB4041268A GB1276089A GB 1276089 A GB1276089 A GB 1276089A GB 4041268 A GB4041268 A GB 4041268A GB 4041268 A GB4041268 A GB 4041268A GB 1276089 A GB1276089 A GB 1276089A
Authority
GB
United Kingdom
Prior art keywords
cores
water
particles
outer layer
pharmaceutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4041268A
Inventor
Joseph Stanley Dwight
Michael Joseph O'brien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB4041268A priority Critical patent/GB1276089A/en
Publication of GB1276089A publication Critical patent/GB1276089A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1276089 Pharmaceutical preparations. PFIZER Ltd 22 Aug 1969 [23 Aug 1968] 40412/ 68 Heading A5B Oral dosage units containing one or more pharmaceutically active ingredients comprising cores having an outer layer thereon consisting of particles of pharmaceutically active material or other material of pharmaceutical utility in a water-soluble matrix are prepared by forming the outer layer by spraying the cores with a suspension of the particles in a liquid medium comprising a water-soluble binding agent and a water-soluble cellulosic film-forming agent dissolved in a mixture of water and a watermiscible pharmaceutically acceptable organic liquid having a boiling point below 90‹C., and evaporating the solvent from the sprayed cores. The organic liquid may be acetone, ethanol or isopropanol; the binding agent may be sucrose, gelatine or gum acacia and the cellulosic film-forming agent may be hydroxypropyl methyl, methyl or sodium carboxymethyl cellulose. The particles deposited may form at least 10% by weight of the dosage unit. The cores may be sprayed with a suspension of a pharmaceutically active ingredient such as paracetamol, the core containing aspirin. The particles of material of pharmaceutical utility may comprise a pigment such as titanium dioxide. The core may be separated from the outer layer by an enteric layer of cellulose acetate phthalate.
GB4041268A 1968-08-23 1968-08-23 Pharmaceutical preparations Expired GB1276089A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB4041268A GB1276089A (en) 1968-08-23 1968-08-23 Pharmaceutical preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4041268A GB1276089A (en) 1968-08-23 1968-08-23 Pharmaceutical preparations

Publications (1)

Publication Number Publication Date
GB1276089A true GB1276089A (en) 1972-06-01

Family

ID=10414777

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4041268A Expired GB1276089A (en) 1968-08-23 1968-08-23 Pharmaceutical preparations

Country Status (1)

Country Link
GB (1) GB1276089A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0013263A2 (en) * 1978-12-05 1980-07-09 Aktiebolaget Hässle A pharmaceutical preparation comprising a cardiac glycoside in combination with a polymer, and a process for preparation thereof
EP0103991A2 (en) * 1982-08-20 1984-03-28 Bristol-Myers Squibb Company Analgesic capsule
EP0105065A1 (en) * 1982-10-05 1984-04-11 Kishan Narain Mathur A pharmaceutical composition for pain relief
US4673527A (en) * 1985-05-20 1987-06-16 Autotrol Corporation Tablet granulation
DK152831B (en) * 1976-09-17 1988-05-24 Richter Gedeon Vegyeszet PROCEDURE FOR THE MANUFACTURING OF BIOLOGICALLY ACTIVE PREPARATIONS WITH REGULATED DELIVERY OF ACTIVE SUBSTANCE AND POLYMER-BASED LIQUID COATING PREPARATIONS FOR USING THE PROCEDURE
EP0384514A2 (en) * 1989-02-21 1990-08-29 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
GB2241168A (en) * 1990-02-26 1991-08-28 Int Medical Research Limited Controlled release product containing salicylate
WO2008129270A2 (en) * 2007-04-18 2008-10-30 Renaissance Pharma Ltd Compositions comprising anti-inflammatory compounds

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK152831B (en) * 1976-09-17 1988-05-24 Richter Gedeon Vegyeszet PROCEDURE FOR THE MANUFACTURING OF BIOLOGICALLY ACTIVE PREPARATIONS WITH REGULATED DELIVERY OF ACTIVE SUBSTANCE AND POLYMER-BASED LIQUID COATING PREPARATIONS FOR USING THE PROCEDURE
EP0013263A3 (en) * 1978-12-05 1981-05-27 Aktiebolaget Hassle A pharmaceutical preparation comprising a cardiac glycoside in combination with a polymer, and a process for preparation thereof
EP0013263A2 (en) * 1978-12-05 1980-07-09 Aktiebolaget Hässle A pharmaceutical preparation comprising a cardiac glycoside in combination with a polymer, and a process for preparation thereof
EP0103991A2 (en) * 1982-08-20 1984-03-28 Bristol-Myers Squibb Company Analgesic capsule
EP0103991A3 (en) * 1982-08-20 1985-05-22 Bristol-Myers Squibb Company Analgesic capsule
EP0105065A1 (en) * 1982-10-05 1984-04-11 Kishan Narain Mathur A pharmaceutical composition for pain relief
US4673527A (en) * 1985-05-20 1987-06-16 Autotrol Corporation Tablet granulation
EP0384514A2 (en) * 1989-02-21 1990-08-29 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
EP0384514A3 (en) * 1989-02-21 1991-04-03 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
GB2241168A (en) * 1990-02-26 1991-08-28 Int Medical Research Limited Controlled release product containing salicylate
US5156849A (en) * 1990-02-26 1992-10-20 Byrne Rynne Holdings Limited Pharmaceutical composition
WO2008129270A2 (en) * 2007-04-18 2008-10-30 Renaissance Pharma Ltd Compositions comprising anti-inflammatory compounds
WO2008129270A3 (en) * 2007-04-18 2008-12-18 Renaissance Pharma Ltd Compositions comprising anti-inflammatory compounds

Similar Documents

Publication Publication Date Title
FI97445B (en) A process for preparing a slow release pharmaceutical composition
US2991226A (en) Long-acting wax-like talc pillage of penicillin
DE2336218C3 (en) Oral dosage form
US3131123A (en) Enteric tablets and manufacture thereof
GB1161439A (en) Pharmaceutical Compositions
GB1465781A (en) Pharmaceutical preparations
CA2072933A1 (en) Mechanically-stable, readily-disintegratable tablets made of small preformed particles containing active ingredients
CA2046739A1 (en) Coated solid medicament form having releasability in large intestine
IE45578L (en) Propranolol capsules
DE69816951D1 (en) Preparation containing cefaclor or cephalexin with a modified release matrix
GB1276089A (en) Pharmaceutical preparations
IL43022A (en) An oral pharmaceutical composition containing cholestyramine coacervate
JPS61221117A (en) Enteric hard capsule
US3383283A (en) Medicinal pellets coated with overlapping porous fatty acid leaflet layers
KR102149020B1 (en) Film-coated tablet having high damp proof property
GB1202148A (en) Pharmaceutical compositions
US2906665A (en) L-amphetamine alginate
ES247237A1 (en) Coated pharmaceutical granules and tablets thereof
GB793808A (en) Sustained action pill
GB1302266A (en)
HU183053B (en) Process for heatstabilizing and form-stabilizing soft gelatine capsules containing active agents inside the envelope utilizable perlingual and buccal application
IE38614B1 (en) Orally administrable corticosteroid preparations
AU4430872A (en) New derivatives of 4-chloro-5-sulfamoyl-anthranilic acid, their preparation and pharmaceutical compositions comprising them
IE35226B1 (en) Pharmaceutical preparations
DE2351860A1 (en) MEDICINAL PRODUCTS CONTAINING SULFOGLYCOPEPTIDES WITH NATURAL OR SYNTHETIC NITROGENIC ORGANIC COMPOUNDS

Legal Events

Date Code Title Description
PS Patent sealed
PE20 Patent expired after termination of 20 years